- Report
- April 2023
- 114 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- March 2019
- 372 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- March 2018
- 369 Pages
Global
From €21269EUR$22,000USD£18,269GBP
- Report
- September 2022
- 216 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- September 2022
- 104 Pages
Europe
From €1450EUR$1,500USD£1,246GBP
- Report
- June 2022
- 38 Pages
Global
From €3862EUR$3,995USD£3,318GBP
- Report
- May 2022
- 246 Pages
Global
From €3916EUR$4,050USD£3,363GBP
- Book
- December 2018
- 277 Pages
From €125EUR$129USD£107GBP
- Report
- February 2024
- 204 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- September 2023
- 200 Pages
Global
From €2899EUR$2,999USD£2,490GBP
- Report
- March 2022
- 172 Pages
Global
From €5963EUR$6,168USD£5,122GBP
- Report
- March 2022
- 180 Pages
Global
From €5577EUR$5,769USD£4,791GBP
- Report
- February 2021
- 109 Pages
United States
From €3527EUR$3,648USD£3,029GBP
- Book
- April 2023
- 688 Pages
- Book
- January 2023
- 1072 Pages
- Book
- September 2022
- 480 Pages
- Book
- October 2019
- 184 Pages
The Arrhythmia market is a subset of the Cardiology market, focusing on the diagnosis and treatment of abnormal heart rhythms. Arrhythmias are caused by a variety of factors, including genetics, lifestyle, and underlying medical conditions. Treatment options include medications, lifestyle changes, and medical devices such as pacemakers and implantable cardioverter defibrillators (ICDs).
The Arrhythmia market is highly competitive, with a range of products and services available from a variety of companies. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Companies in the market include Abbott, Boston Scientific, Medtronic, St. Jude Medical, and Biotronik. Show Less Read more
